Inclisiran injection Uses, Dosage, Side Effects and Interactions
Leqvio
Leqvio was the first inclisiran injection product the FDA approved, in December 2021. No generic is listed as injections.
Inclisiran injection is a cholesterol-lowering medicine given under the skin that reduces LDL cholesterol in adults with hypercholesterolemia and in people 12 and older with familial hypercholesterolemia.
Quick links
Ask Anything About Inclisiran injectionType a question in your own words. Answered from its FDA label in seconds.Every other section of this page is in the dots on the left edge of your screen: point at one to see where it goes.Every other section of this page is one tap away: use the arrow tab on the left edge of your screen.
Inclisiran injection in Short
What it treatsInclisiran injection is used along with diet and exercise to lower LDL-C (“bad” cholesterol). Leqvio is the product supported here. Leqvio is used in adults with hypercholesterolemia (high cholesterol).
- How you get it Prescription only
- Comes asInjection (under the skin)
- Important safety informationWarnings and precautions Read the warnings and precautions for your exact product.
- Generic launchsometime in 2036 Our estimate for the first generic of Leqvio
The Pharmacist’s Take
Inclisiran (Leqvio) is a cholesterol-lowering injection, on the U.S. market since about 2021 with no generic, that silences the liver’s instructions for making a protein called PCSK9 so the liver clears more LDL (“bad”) cholesterol; it is usually added to a statin when LDL is still too high. Most people tolerate it well, noticing at most some pain, redness or rash where the shot went in. Watch for a serious allergic reaction, and get emergency help for swelling of the face, lips, tongue or throat after a dose. It may harm an unborn baby, so tell your prescriber if you are or could become pregnant.
Key Takeaways From the HelloPharmacist Team
- A healthcare professional gives every dose, with one shot, another at 3 months, then one every 6 months.
- Keep taking your statin unless told otherwise, since inclisiran works alongside it and is not expected to interact with other medicines.
- Put the next injection date on your calendar before you leave the clinic, since doses are months apart and easy to forget.
- Expect a follow-up cholesterol blood test to confirm the injections are bringing your LDL down.
Patient Information Guide for Inclisiran injection
What It’s Used For
Inclisiran injection lowers LDL cholesterol along with diet and exercise. Supported uses for Leqvio:
- Adults with hypercholesterolemia (high cholesterol)
- Adults and children 12 and older with heterozygous familial hypercholesterolemia (HeFH)
- Children 12 and older with homozygous familial hypercholesterolemia (HoFH)
Trials have shown that lowering LDL-C reduces the risk of major adverse cardiovascular events (such as heart attack and stroke) in adults at increased risk who are treated with statins or PCSK9 antibody medicines added to a statin.
How It Works
Inclisiran is a small interfering RNA (siRNA) that is attached to a sugar molecule so liver cells take it up. Inside the liver, it triggers the breakdown of the message (mRNA) for PCSK9.
With less PCSK9, liver cells recycle more LDL receptors and display more of them on their surface. This clears more LDL cholesterol from the blood.
Drug Class
WHO drug family
- Other lipid modifying agents
Detailed classifications and sources
The FDA sorts a drug’s active ingredient by how it works, what it does in the body and its chemical structure, and gives it one main drug class.
Drug Class
Established Pharmacologic Class (EPC)None. The FDA’s index lists no class of any kind for Inclisiran injection.
The main drug class the FDA gives it. It is the class named on the drug’s label.
What It Does in the Body
Physiologic effect (PE)None listed for Inclisiran injection in the FDA’s index.
From our Patient Information GuideInclisiran is a small interfering RNA (siRNA) that is attached to a sugar molecule so liver cells take it up. Inside the liver, it triggers the breakdown of the message (mRNA) for PCSK9. Read How Inclisiran injection Works
A change it makes in how the body works.
Drug Family
WHO ATC classification- Other lipid modifying agents
How the World Health Organization groups it: by the part of the body it acts on and what it treats.
The description under What It Does in the Body is written by the HelloPharmacist team, not the FDA. Read the FDA’s definitions. The drug family is the World Health Organization’s ATC classification, from the U.S. National Library of Medicine’s RxClass. Reference only, not medical advice.
Dosage
Leqvio is injected under the skin by a healthcare professional. The schedule is a first dose, a second dose at 3 months, then one dose every 6 months.
Food does not matter because it is an injection.
- If a dose is missed by less than 3 months, you get it and stay on your original schedule.
- If a dose is missed by more than 3 months, you restart: a dose, another at 3 months, then every 6 months.
Always follow your prescriber’s directions.
Typical Doses
Your prescriber chooses your dose, so take it exactly as prescribed.
High LDL (bad) cholesterol, including inherited forms (familial hypercholesterolemia)
For adults and children 12 years and older
Starting dose 284 mg as one injection under the skin
Usual dose 284 mg as one injection under the skin every 6 months
- 284 mg administered as a single subcutaneous injection initially, again at 3 months, and then every 6 months
Good to know
- Given by a healthcare professional into the abdomen, upper arm, or thigh.
- If a planned dose is missed by less than 3 months, give it and keep the original schedule.
- If missed by more than 3 months, restart: initially, again at 3 months, then every 6 months.
Side Effects
Most side effects in trials were mild. The most common were:
Common side effects
- Injection site reactions (pain, redness, rash)
- Joint pain (arthralgia)
- Bronchitis
- Headache (more often seen in children 12 and older with HeFH)
When to get medical help
- Get medical help right away for signs of a serious allergic reaction, such as anaphylaxis (severe whole-body allergic reaction) or angioedema (swelling of the face, lips, tongue or throat).
- Seek prompt care if you develop rash, itching or hives after a dose.
- Tell your prescriber if you become pregnant while receiving it.
Serious allergic reactions, including anaphylaxis and angioedema, have been reported. Seek medical help right away if you notice swelling, trouble breathing, or widespread rash, itching or hives.
Warnings and Precautions
- Serious allergic reactions such as anaphylaxis and angioedema have occurred. Seek prompt medical attention if you notice signs.
- Pregnancy: it may cause fetal harm based on how it works. Tell your prescriber if you are pregnant or become pregnant.
Interactions
No formal interaction studies were done, but the label does not expect problems.
- It is not processed by cytochrome P450 enzymes or transporters, so drugs that affect them are not expected to change it.
- It did not meaningfully change atorvastatin or rosuvastatin levels.
Not a complete list. The label covers the interactions the manufacturer studied or reported, and our own interaction database does not cover every medicine either. Bring your full medication list, including vitamins and herbal products, to your pharmacist.
Before You Start
- Do not use if you have had a serious allergic reaction to inclisiran or its ingredients.
- Tell your doctor if you are pregnant or planning pregnancy.
- Discuss breastfeeding with your doctor.
- Not established in children under 12 with HeFH or HoFH.
- Older adults: no overall differences in safety or effectiveness.
- Kidney: no dose change for mild to severe impairment; not studied in end stage kidney disease.
- Liver: no dose change for mild to moderate impairment; not studied in severe impairment.
Half-Life and How Your Body Processes It
After an injection under the skin, blood levels peak in about 4 hours and are undetectable after 24 to 48 hours. It goes mainly to the liver, where it works. Its half-life is about 9 hours, and it does not build up with repeated doses. It is broken down by nucleases (enzymes that break down RNA), not liver CYP450 enzymes, and about 16% is cleared by the kidneys.
Storage
Store LEQVIO at controlled room temperature 20°C to 25°C (68°F to 77°F) with allowable excursions between 15°C and 30°C (59°F and 86°F) .
Written from the FDA-approved label with AI and reviewed by our pharmacy team. How we use AI
Inclisiran injection: Pharmacist Answers to Common Questions
Quick, plain-English answers to the questions patients ask most about Inclisiran injection — the kind of thing our pharmacy team would talk through with you at the counter.
What is inclisiran injection used for?
How often do I get inclisiran injection?
What happens if I miss a dose of inclisiran injection?
How long does inclisiran injection take to work?
What side effects should I expect?
Can I take inclisiran injection with my statin or other medicines?
Is inclisiran injection available over the counter?
When was inclisiran injection first available?
What is the brand name of inclisiran injection?
What is the generic name of Leqvio?
What strengths does inclisiran injection come in?
Where can I read the inclisiran injection prescribing information (package insert)?
Answers drafted from the FDA-approved label with AI and reviewed by our pharmacy team. How we use AI
Ask Anything About Inclisiran injection
Skip the scrolling. Ask in your own words and get an answer from Inclisiran injection’s FDA label and our pharmacists’ own work.
Name another drug or a supplement in your question and we check both.
AI answers from FDA labels and our own records, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.How this works
- Sources: Inclisiran injection’s FDA label, including the clinical studies it reports, and the label of any drug you name; our pharmacists’ own work, such as our Do Not Crush list and our published answers to readers’ questions; our pharmacy prices and the Natural Medicines supplement database.
- Written by AI: Answers are written by AI from those sources, and AI can make mistakes. Check what you read here with your doctor or pharmacist before you act on it.
- Reviewed afterward: Our pharmacy team reviews every question and answer afterward to check it for accuracy, and when we find an error, we correct how the box answers. Read more in How we use AI.
- Not medical advice. In an emergency, call 911, Poison Control at 1-800-222-1222, or 988.
More About Inclisiran injection on HelloPharmacist
Still have a question? A licensed pharmacist answers for free, as soon as they can.Inclisiran injection Forms and Strengths (How It Comes)
Inclisiran injection comes in 1 dose form, the injection. Different forms and brands can have different approved uses, doses, schedules, and directions. Follow the instructions for your exact product, and do not switch forms without guidance from your prescriber or pharmacist.
Need a version that does not list lactose, a gluten source, a dye or gelatin? Inactive ingredients differ by manufacturer: see Inclisiran injection inactive ingredients by manufacturer.
Injection
How this form is used
- Leqvio is used with diet and exercise to lower LDL-C in adults with hypercholesterolemia.
- Leqvio is used in adults and children 12 and older with HeFH.
- Leqvio is used in children 12 and older with HoFH.
- Leqvio is given under the skin of the abdomen, upper arm, or thigh by a healthcare professional.
- Leqvio is given initially, again at 3 months, and then every 6 months.
- Leqvio should not be injected into skin that is sunburned, rashy, inflamed, or infected.
- Leqvio should look clear and colorless to pale yellow before use.
Inclisiran injection on the U.S. Market: Products, Makers and Brands
How Inclisiran injection appears in the FDA’s National Drug Code Directory — including its dosage forms, strengths, brand names, manufacturers, and FDA-listed product records. These are directory records, not sales or prescription volume.
1 company lists 1 Inclisiran injection product record with the FDA, mostly as injection; the earliest marketing or approval year on record is 2021. The one brand name in the directory today is Leqvio; the rest are generics.
How Widely Inclisiran injection Is Used (Medicaid Data)
How many Inclisiran injection prescriptions Medicaid paid for in Q1–Q4 2025, every brand, strength and form together. Medicaid is one program, so total U.S. use is higher.
How commonly is Inclisiran injection prescribed? Of the 1,682 medications we measure, Inclisiran injection ranks #1,171 by Medicaid prescriptions — more than 30% of them.
Utilization by Inclisiran injection product
Pick a strength and form to see its own numbers. Brand and generic versions are counted together.
1.5 ML inclisiran 189 MG/ML Prefilled Syringe
1 of 2 listed NDCs had Medicaid claims. RxNorm 2588263
Dollars are what Medicaid paid before the rebates drug makers send back, so its real cost is lower.
Source: Medicaid State Drug Utilization Data (CMS), all states. 1 of the 2 listed Inclisiran injection NDCs had Medicaid claims.
Compare Inclisiran injection Products
A representative set of FDA-listed product records for Inclisiran injection — across manufacturers, strengths, and dosage forms, grouped by form with each product’s manufacturer and how the FDA approved it. The same medicine may be made and packaged by different companies, so a single drug can have many directory entries. (It’s also why a refill can look different — a new shape, color, or box — even though it contains the same medication.)
| Strength | Route | Manufacturer / Labeler | Category ⓘ | Details |
|---|---|---|---|---|
| 💊Injection | ||||
| 284 mg/1.5 mL | Subcutaneous | Novartis Pharmaceuticals Corporation | NDA | View NDC → |
Showing 1 of 1 products — FDA National Drug Code Directory. See every product, package size and price: browse all 1 Inclisiran injection NDCs →
Inclisiran injection Side Effects Reported to the FDA (FAERS)
After a medicine reaches the market, patients, doctors and drugmakers can send the FDA reports of problems they think may be linked to it. Here’s what’s been reported for Inclisiran injection — a signal of what to watch for, not proof the drug caused it.
Source: openFDA, from the FDA Adverse Event Reporting System (FAERS). These are voluntary reports — they don’t prove the drug caused the effect, and counts reflect how often something was reported, not how often it actually happens. Reports also often name the very problem the medicine is taken for — a common reason to file one is that the drug didn’t help — so for a pain reliever you may see “pain” high on the list; that points to why the report was filed, not to the drug causing the symptom. This counts every report that lists Inclisiran injection in any role, so the total runs higher than the FDA’s official dashboard, which counts only cases where the drug is the suspect. For the authoritative figures, see the FDA FAERS Public Dashboard. Always talk to your pharmacist or doctor.
Inclisiran injection FDA Approval History
How Inclisiran injection went from FDA review to the pharmacy shelf — the key milestones in its regulatory journey.
Source: Drugs@FDA.
Inclisiran injection Recall History
A recall is when a specific batch of a medicine is pulled from the market — usually a manufacturing issue, not a problem with the drug itself. Class I is most serious, Class III least.
The FDA’s enforcement reports list no Inclisiran recalls since July 2021.
✅No Inclisiran recalls on record since July 2021Source: FDA enforcement (recall) reports, via openFDA; our copy was last updated Nov 19, 2026.
Inclisiran injection in RxNorm: From Ingredient to Every Form and Strength
RxNorm is the U.S. National Library of Medicine’s standard name for every version of a medicine, the code pharmacy and prescribing systems share. This page starts from one ingredient (IN); each dose form (SCDF) branches from it, and each exact strength (SCD) from its form. Combination products are separate concepts with their own pages.
- Dose forms
- 1
- Strengths
- 1
- Forms in current FDA listings
- 1 of 1
RxCUI 2588243 -
Dose form (SCDF) Prefilled SyringeIn current FDA listings
RxCUI 2588262Its strength (SCD)-
1.5 mL inclisiran 189 mg/mL
RxCUI 2588263
-
1.5 mL inclisiran 189 mg/mL
RxNorm is the U.S. National Library of Medicine’s normalized drug vocabulary. Its concept hierarchy can include forms that are not currently marketed; the status on each branch compares that concept with current FDA listings. RxCUIs identify vocabulary concepts, not individual packages or manufacturers.
Inclisiran injection Supply and Shortage Status
Whether Inclisiran injection is in short supply in the U.S. right now, plus any shortage history the FDA has on record. A shortage usually reflects a manufacturing or demand issue — not a safety problem with the drug.
Source: openFDA, from the FDA Drug Shortages database.
Inclisiran injection Brand Names
Inclisiran injection has one brand name on record: Leqvio. A brand name is one company's name for the medicine; a generic has the same active ingredient under its generic name.
Who Makes Inclisiran injection: Manufacturers and Labelers
One company lists Inclisiran injection products with the FDA. By number of product records, the largest are Novartis Pharmaceuticals Corporation. Labelers include manufacturers and repackagers; the product in your bottle depends on which one your pharmacy stocks.
Sources for This Inclisiran injection Page
Core label, product, RxNorm, safety, and utilization data on this page come from the sources identified below. AI-written, editorial, and licensed sections are labeled separately.
How this page is built
HelloPharmacist combines public FDA and NLM records and does not author the underlying clinical facts. The plain-language sections are written with AI from the FDA-approved label text and reviewed by our pharmacy team before publication. Novartis Pharmaceuticals Corporation is the representative DailyMed label linked for verification and dates. This is general education, not medical advice: always talk to your doctor or pharmacist about your own medicines. How we build and review drug pages →